ITEMS IN AFP WITH KEYWORD:

Influenza

Oct 15, 2020 Issue
Influenza Vaccination: Updated 2020-2021 Recommendations from ACIP [Practice Guidelines]

The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has released its recommendations for routine influenza vaccination in the 2020–2021 season.


Aug 15, 2020 Issue
Oseltamivir of Uncertain Benefit in Patients with Flulike Symptoms [POEMs]

Although the authors report that compared with usual care oseltamivir shortens the duration of symptoms, the methodologic biases in this study make their conclusions suspect.


Dec 15, 2019 Issue
Baloxavir Marboxil (Xofluza) for Influenza [STEPS]

Single-dose baloxavir should be limited to ill patients who cannot tolerate or comply with a course of oseltamivir. For otherwise healthy adults with confirmed influenza or influenza-like illness, the high cost of baloxavir may not justify the one-day reduction in symptoms of a self-limited illness.


Dec 15, 2019 Issue
Baloxavir Reduces Symptom Duration Similar to Oseltamivir, Primarily Within 24 Hours of Symptom Onset [POEMs]

Baloxavir has similar efficacy to oseltamivir (Tamiflu) (33-hour reduction in duration of symptoms compared with placebo) and, like oseltamivir, is most effective when given within 24 hours of the onset of symptoms.


Dec 15, 2019 Issue
Influenza: Diagnosis and Treatment [Article]

For most outpatients, influenza is diagnosed clinically, and laboratory confirmation is not necessary. Laboratory testing may be useful in hospitalized patients with suspected influenza and in patients for whom a confirmed diagnosis will change treatment decisions. Learn which point-of-care tests are most accurate, and which antivirals are preferred for treatment.


Oct 15, 2019 Issue
Influenza Vaccination: Updated Recommendations from ACIP [Practice Guidelines]

The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) has released its recommendations for routine influenza vaccination in the 2019–2020 season.


Aug 1, 2019 Issue
Vaccines for Preventing Influenza in Healthy Children, Healthy Adults, and Older Adults [Cochrane for Clinicians]

Influenza vaccination reduces rates of laboratory-confirmed influenza and symptomatic influenza-like illness in healthy children, healthy adults, and older adults. There is no consistent evidence that influenza vaccination reduces school absenteeism in children, parental absenteeism from work, or ad...


Oct 15, 2018 Issue
Influenza Vaccination Recommendations for 2018-2019: Updates from ACIP [Practice Guidelines]

The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) has released its recommendations for routine influenza vaccination in the 2018–2019 season.


Dec 15, 2017 Issue
In Hospitalized Patients with Influenza and an Infiltrate, Adding Clarithromycin and Naproxen to Oseltamivir Improves Outcomes [POEMs]

Adding clarithromycin and naproxen to oseltamivir significantly lowered all-cause mortality at 30 days and at 90 days. This study was limited by its open-label design. The outcome of mortality would not be subject to observer bias, though, and the groups were balanced.


Oct 15, 2017 Issue
Influenza Vaccination Recommendations for 2017-2018: Updates from ACIP [Practice Guidelines]

The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) has released its recommendations on influenza vaccination for the 2017–2018 season. In this update, ACIP announces the currently available vaccine products, reviews license and labeling changes, and issues recommendations for specific populations.


Pages: 1 2 3 4 5 6 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now